References
- Hoistein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991; 253: 49–53
- Levine J, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature 1991; 351–453
- Mashal R, Shtalrid M, Talpaz M. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood. 1990; 75: 180–189
- Lane D P. p53, guardian of the genome. Nature 1992; 358: 15–16
- Sugimoto K, Toyoshima H, Sakai R. Mutations of the p53 gene in lymphoid leukemia. Blood. 1991; 77: 1153–1156
- Gaidano G, Ballerini P, Gong J Z. p53 mutations in human lymphoid malignancies: association with Burkitt's lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413–5417
- Sugimoto K, Hirano N, Toyoshima H. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood. 1993; 81: 3022
- Prococimer M, Rotter V. Structure and function of p-53 in normal cells and their aberrations in cancer cells: projection on the hematological cell lineages. Blood. 1994; 84: 2391–2411
- Felix C A, Nau M M, Takahashi T. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992; 89: 640–647
- Wada M, Bartram C R, Nakamura H. Analysis of p53 mutations in a large series of lymphoid malignancies of childhood. Blood. 1993; 82: 3163–3169
- Oliner J D, Kinzler K W, Meltzer P S, George D L, Vogelstein B. Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature 1992; 358: 80–83
- Meltzer P S. MDM2 and p53: a question of balance. J Natl Cancer Inst. 1994; 84: 1265–1266
- Ridge S A, Dyer M, Greaves M F, Wiedemann L M. Lack of MDM2 amplification in human leukaemia. Br J Haematol. 1994; 86: 407–409
- Bueso-Ramos C E, Yang Y, De Leon E, McCown P, Stass S A, Albitar M. The human MDM-2 oncogene is overexpressed in leukemias. Blood 1993; 82: 2617–2623
- Quensel B, Preudhomm C, Oscier D. Overexpression of the MDM2 gene is found in some cases of haematological malignancies. Br J Haematol. 1994; 88
- Zhou M, Yeager A M, Smith S D, Findley H W. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood. 1995; 85: 1608–1614
- Kaplan E L, Meier P. Nonparametic estimation from incomplete observations. J Am State Accoc. 1958; 53: 457–481
- Zhang W, Hu G, Estey E, Hester J, Deisseroth A. Altered confirmation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene. 1992; 7: 1645–1647
- Gown A M, De Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunol. 1993; 1: 256–266
- Bueso-Ramos C E, Manshouri T, Haidar M A, Huh Y O, Keating M J, Albitar M. Multiple patterns of MDM-2 deregulation in human leukemias: implication in leukemogenesis and prognosis. Leuk Lymphoma. 1995; 17: 13–18